Geriatric Assessment in Predicting Chemotherapy Toxicity and Vulnerabilities in Older Patients With Cancer

This randomized clinical trial studies a geriatric assessment intervention in predicting chemotherapy toxicity and vulnerabilities (or weakness) in older patients with cancer. Assessing patients' functional status, comorbidities, psychological state, social support, nutritional status, and cognitive function before treatment may help identify vulnerabilities, improve care, and decrease chemotherapy side effects in older patients with cancer.

Inclusion Criteria: * Diagnosis of a solid tumor malignancy (any stage) * Scheduled to start a new chemotherapy regimen (any line, combination cytotoxic chemotherapy with targeted agents are allowed) * English, Spanish, and/or Chinese speaking * Able to provide written informed consent Exclusion Criteria: * Not fluent in English, Spanish and/or Chinese (because not all questionnaires have been validated in other languages)